Author: Paige Twenter

American Cancer Society recognizes MIT researcher with medal of honor

In early March, the American Cancer Society named Tyler Jacks, PhD, the recipient of its 2026 medal of honor, its most prestigious award. Dr. Jacks is president of Break Through Cancer, a nonprofit initiative that unites U.S. cancer institutes to…

GLP-1s tied to improved survival in colorectal cancer

Use of GLP-1 medications was associated with lower long-term mortality among patients with colorectal cancer and obesity, according to research presented at an oncology conference. Over a 10-year period, GLP-1 drugs were associated with about 5.6 fewer deaths per 100…

Mark Cuban drug firm adds cancer biosimilar

Mark Cuban Cost Plus Drug Co. has added Vegzelma, a biosimilar indicated for six cancer types, to its marketplace for hospitals and other healthcare providers. The company plans to expand its biosimilar offerings amid growing demand for biologics among health…

RWJBarnabas, Rutgers collaborate on oncology specialty care

West Orange, N.J.-based RWJBarnabas and Rutgers Cancer Institute in New Brunswick, N.J., are joining to expand access to oncology specialty care services. The two organizations are working together to add oncology specialty services at University Hospital, a 519-bed academic medical…

Lung cancer diagnoses rising among young, middle-age women

Although lung cancer incidence rates are declining, more young and middle-age women are being diagnosed at higher rates than men, CNN reported Nov. 25.

Breast cancer rates rise among young women, Asian Americans

From 2012 to 2021, breast cancer incidence has risen 1%, with steep increases among young women and Asian American/Pacific Islander women, according to the American Cancer Society.

No survival advantage for double mastectomies over other treatments, study suggests

Double mastectomies have similar survival rates to lumpectomies and single mastectomies, according to research published July 25 in JAMA Oncology.

FDA approves 1st AI-powered device for skin cancer detection

The FDA recently approved the nation's first artificial intelligence-powered medical device that detects skin cancer.

5 cancer types with highest risk of a substance use disorder: Study

Substance use disorders are highly variable among cancer patient populations, and new research points to five cancers with the highest prevalence of SUDs, according to a study published Jan. 11 in JAMA.

Study challenges 'gold standard' of cancer opioid treatment

Morphine is widely considered the "gold-standard treatment" for pain during cancer care, but a new study found the drug was not superior to other opiates.